Frank Park - Publications

Affiliations: 
Medical College of Wisconsin, Milwaukee, WI, United States 
Area:
Physiology Biology, Pharmacology, Molecular Biology

48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Swanson M, Yun J, Collier DM, Seif C, Yang CY, Regner KR, Park F. Identification of CDC20 in various forms of acute and chronic kidney injury in mice. American Journal of Physiology. Renal Physiology. PMID 37348027 DOI: 10.1152/ajprenal.00302.2022  0.343
2022 Swanson ML, Regner KR, Moore BM, Park F. Cannabinoid Type 2 Receptor Activation Reduces the Progression of Kidney Fibrosis Using a Mouse Model of Unilateral Ureteral Obstruction. Cannabis and Cannabinoid Research. PMID 35196117 DOI: 10.1089/can.2021.0127  0.306
2019 Pressly JD, Soni H, Jiang S, Wei J, Liu R, Moore BM, Adebiyi A, Park F. Activation of the cannabinoid CB2 receptor increases renal perfusion. Physiological Genomics. PMID 30707046 DOI: 10.1152/physiolgenomics.00001.2019  0.361
2018 Keri KC, Regner KR, Dall AT, Park F. Urinary exosomal expression of activator of G protein signaling 3 in polycystic kidney disease. Bmc Research Notes. 11: 359. PMID 29880041 DOI: 10.1186/s13104-018-3467-6  0.365
2017 Pressly JD, Mustafa SM, Abidi A, Alghamdi S, Pandey P, Roy KK, Doerksen R, Moore BM, Park F. Selective cannabinoid 2 receptor stimulation reduces tubular epithelial cell damage following renal ischemia-reperfusion injury. The Journal of Pharmacology and Experimental Therapeutics. PMID 29187590 DOI: 10.1124/Jpet.117.245522  0.381
2017 Park F, Miller D. Role of lysophosphatidic acid and its receptors in the kidney. Physiological Genomics. physiolgenomics.0007. PMID 28939644 DOI: 10.1152/Physiolgenomics.00070.2017  0.404
2017 Park F, Potukuchi PK, Moradi H, Kovesdy CP. Cannabinoids and the Kidney: Effects in Health and Disease. American Journal of Physiology. Renal Physiology. ajprenal.00290.2017. PMID 28747360 DOI: 10.1152/ajprenal.00290.2017  0.368
2017 Pressly JD, Hama T, Brien SO, Regner KR, Park F. TRIP13-deficient tubular epithelial cells are susceptible to apoptosis following acute kidney injury. Scientific Reports. 7: 43196. PMID 28256593 DOI: 10.1038/srep43196  0.358
2016 Hama T, Park F. Heterotrimeric G-protein signaling in polycystic kidney disease. Physiological Genomics. physiolgenomics.0002. PMID 27199453 DOI: 10.1152/physiolgenomics.00027.2016  0.324
2015 Rasmussen SA, Kwon M, Pressly JD, Blumer JB, Regner KR, Park F. Activator of G-protein Signaling 3 Controls Renal Epithelial Cell Survival and ERK5 Activation. Journal of Molecular Signaling. 10: 6. PMID 27096004 DOI: 10.5334/1750-2187-10-5  0.371
2015 Lenarczyk M, Pressly JD, Arnett J, Regner KR, Park F. Localization and expression profile of Group I and II Activators of G-protein Signaling in the kidney. Journal of Molecular Histology. 46: 123-36. PMID 25533045 DOI: 10.1007/s10735-014-9605-0  0.312
2014 White SM, North LM, Haines E, Goldberg M, Sullivan LM, Pressly JD, Weber DS, Park F, Regner KR. G-protein βγ subunit dimers modulate kidney repair after ischemia-reperfusion injury in rats. Molecular Pharmacology. 86: 369-77. PMID 25028481 DOI: 10.1124/Mol.114.092346  0.488
2013 Bi D, Toyama K, Lemaître V, Takai J, Fan F, Jenkins DP, Wulff H, Gutterman DD, Park F, Miura H. The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling. The Journal of Biological Chemistry. 288: 15843-53. PMID 23609438 DOI: 10.1074/Jbc.M112.427187  0.308
2012 Kwon M, Pavlov TS, Nozu K, Rasmussen SA, Ilatovskaya DV, Lerch-Gaggl A, North LM, Kim H, Qian F, Sweeney WE, Avner ED, Blumer JB, Staruschenko A, Park F. G-protein signaling modulator 1 deficiency accelerates cystic disease in an orthologous mouse model of autosomal dominant polycystic kidney disease. Proceedings of the National Academy of Sciences of the United States of America. 109: 21462-7. PMID 23236168 DOI: 10.1073/Pnas.1216830110  0.447
2012 Bangaru ML, Park F, Hudmon A, McCallum JB, Hogan QH. Quantification of gene expression after painful nerve injury: validation of optimal reference genes. Journal of Molecular Neuroscience : Mn. 46: 497-504. PMID 21863315 DOI: 10.1007/S12031-011-9628-X  0.306
2011 Yu H, Fischer G, Jia G, Reiser J, Park F, Hogan QH. Lentiviral gene transfer into the dorsal root ganglion of adult rats. Molecular Pain. 7: 63. PMID 21861915 DOI: 10.1186/1744-8069-7-63  0.301
2011 Regner KR, Nozu K, Lanier SM, Blumer JB, Avner ED, Sweeney WE, Park F. Loss of activator of G-protein signaling 3 impairs renal tubular regeneration following acute kidney injury in rodents. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 1844-55. PMID 21343176 DOI: 10.1096/Fj.10-169797  0.518
2011 Roman RJ, Akbulut T, Park F, Regner KR. 20-HETE in acute kidney injury. Kidney International. 79: 10-3. PMID 21157458 DOI: 10.1038/Ki.2010.396  0.702
2010 Nadella R, Blumer JB, Jia G, Kwon M, Akbulut T, Qian F, Sedlic F, Wakatsuki T, Sweeney WE, Wilson PD, Lanier SM, Park F. Activator of G protein signaling 3 promotes epithelial cell proliferation in PKD. Journal of the American Society of Nephrology : Jasn. 21: 1275-80. PMID 20488951 DOI: 10.1681/Asn.2009121224  0.731
2010 Jia G, Kwon M, Liang HL, Mortensen J, Nilakantan V, Sweeney WE, Park F. Chronic treatment with lisinopril decreases proliferative and apoptotic pathways in autosomal recessive polycystic kidney disease. Pediatric Nephrology (Berlin, Germany). 25: 1139-46. PMID 20229187 DOI: 10.1007/S00467-010-1477-2  0.471
2009 Liang HL, Arsenault J, Mortensen J, Park F, Johnson CP, Nilakantan V. Partial attenuation of cytotoxicity and apoptosis by SOD1 in ischemic renal epithelial cells. Apoptosis : An International Journal On Programmed Cell Death. 14: 1176-89. PMID 19685188 DOI: 10.1007/S10495-009-0393-Z  0.387
2009 Akbulut T, Regner KR, Roman RJ, Avner ED, Falck JR, Park F. 20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism. American Journal of Physiology. Renal Physiology. 297: F662-70. PMID 19570883 DOI: 10.1152/Ajprenal.00146.2009  0.713
2009 Park F, Sweeney WE, Jia G, Akbulut T, Mueller B, Falck JR, Birudaraju S, Roman RJ, Avner ED. Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD. American Journal of Physiology. Renal Physiology. 296: F575-82. PMID 19129252 DOI: 10.1152/Ajprenal.90705.2008  0.729
2009 Park F, Sweeney WE, Jia G, Akbulut T, Mueller B, Falck JR, Birudaraju S, Roman RJ, Avner ED. Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD (American Journal of Physiology - Renal Physiology (2009) 296, (F575-F582) DOI: 10.1152/ajprenal.90705.2008) American Journal of Physiology-Renal Physiology. 297. DOI: 10.1152/Ajprenal.Zh2-5691-Corr.2009  0.716
2008 Akbulut T, Park F. Gene therapy to the kidney using viral vectors. Paediatriki. 71: 177-185. PMID 20827394  0.717
2008 Park F, Sweeney WE, Jia G, Roman RJ, Avner ED. 20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease. Journal of the American Society of Nephrology : Jasn. 19: 1929-39. PMID 18596124 DOI: 10.1681/Asn.2007070771  0.495
2008 Nilakantan V, Maenpaa C, Jia G, Roman RJ, Park F. 20-HETE-mediated cytotoxicity and apoptosis in ischemic kidney epithelial cells. American Journal of Physiology. Renal Physiology. 294: F562-70. PMID 18171997 DOI: 10.1152/Ajprenal.00387.2007  0.374
2007 Park F. Lentiviral vectors: are they the future of animal transgenesis? Physiological Genomics. 31: 159-73. PMID 17684037 DOI: 10.1152/Physiolgenomics.00069.2007  0.3
2006 Oh T, Peister A, Ohashi K, Park F. Transplantation of murine bone marrow stromal cells under the kidney capsule to secrete coagulation factor VIII. Cell Transplantation. 15: 637-45. PMID 17176615 DOI: 10.3727/000000006783981620  0.318
2006 Park F, Gow KW. Gene therapy: future or flop. Pediatric Clinics of North America. 53: 621-38. PMID 16872996 DOI: 10.1016/J.Pcl.2006.05.003  0.312
2006 Tae KO, Gui HQ, Hae YK, Park F, Seung TK. Correction of anemia in uremic rats by intramuscular injection of lentivirus carrying an erythropoietin gene American Journal of Nephrology. 26: 326-334. PMID 16825758 DOI: 10.1159/000094401  0.376
2006 Qian Z, Haessler M, Lemos JA, Arsenault JR, Aguirre JE, Gilbert JR, Bowler RP, Park F. Targeting vascular injury using Hantavirus-pseudotyped lentiviral vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 694-704. PMID 16431160 DOI: 10.1016/J.Ymthe.2005.11.016  0.323
2005 Painter RG, Lanson NA, Jin Z, Park F, Wang G. Conditional expression of a suicide gene by the telomere reverse transcriptase promoter for potential post-therapeutic deletion of tumorigenesis. Cancer Science. 96: 607-13. PMID 16128746 DOI: 10.1111/J.1349-7006.2005.00085.X  0.327
2004 Arsenault JR, Hattan N, Chilian WM, Varner KJ, Park F. 738. Optimizing a Lentiviral Vector System for Efficient Transduction of Primary Rat Cardiovascular Cells In Vitro Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.691  0.376
2004 Painter RG, Lanson NA, Jin Z, Park F, Wang G. 415. Conditional Expression of a Suicide Gene by the Telomere Reverse Transcriptase Promoter for Post-Therapeutic Deletion of Insertional Mutagenesis Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.432  0.338
2004 Gilbert JR, Park F. 334. Micro-Environmental Effects on Gene Transfer by Pseudotyped Lentiviral Vectors Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.276  0.372
2003 Sirin O, Park F. Regulating gene expression using self-inactivating lentiviral vectors containing the mifepristone-inducible system. Gene. 323: 67-77. PMID 14659880 DOI: 10.1016/J.Gene.2003.09.006  0.349
2003 Park F. Correction of bleeding diathesis without liver toxicity using arenaviral-pseudotyped HIV-1-based vectors in hemophilia A mice. Human Gene Therapy. 14: 1489-94. PMID 14577928 DOI: 10.1089/104303403769211691  0.301
2002 Ohashi K, Park F, Schwall RH, Kay MA. Efficient gene transduction to cultured hepatocytes by HIV-1 derived lentiviral vector Transplantation Proceedings. 34: 1431-1433. PMID 12176427 DOI: 10.1016/S0041-1345(02)02916-0  0.333
2002 Ohashi K, Park F, Kay MA. Role of hepatocyte direct hyperplasia in lentivirus-mediated liver transduction in vivo Human Gene Therapy. 13: 653-663. PMID 11916488 DOI: 10.1089/10430340252837242  0.308
2001 Park F, Kay MA. Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo Molecular Therapy. 4: 164-173. PMID 11545606 DOI: 10.1006/Mthe.2001.0450  0.33
2000 Szentiványi M, Park F, Maeda CY, Cowley AW. Nitric oxide in the renal medulla protects from vasopressin-induced hypertension. Hypertension. 35: 740-5. PMID 10720588 DOI: 10.1161/01.Hyp.35.3.740  0.445
1999 Miyata N, Park F, Li XF, Cowley AW. Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. The American Journal of Physiology. 277: F437-46. PMID 10484527 DOI: 10.1152/Ajprenal.1999.277.3.F437  0.441
1999 Wu F, Park F, Cowley AW, Mattson DL. Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney. The American Journal of Physiology. 276: F874-81. PMID 10362776 DOI: 10.1152/Ajprenal.1999.276.6.F874  0.333
1998 Park F, Zou AP, Cowley AW. Arginine vasopressin-mediated stimulation of nitric oxide within the rat renal medulla. Hypertension. 32: 896-901. PMID 9822450 DOI: 10.1161/01.Hyp.32.5.896  0.421
1998 Park F, Koike G, Cowley AW. Regional time-dependent changes in vasopressin V2 receptor expression in the rat kidney during water restriction. The American Journal of Physiology. 274: F906-13. PMID 9612328 DOI: 10.1152/Ajprenal.1998.274.5.F906  0.336
1997 Park F, Mattson DL, Roberts LA, Cowley AW. Evidence for the presence of smooth muscle alpha-actin within pericytes of the renal medulla. The American Journal of Physiology. 273: R1742-8. PMID 9374818 DOI: 10.1152/Ajpregu.1997.273.5.R1742  0.314
1997 Park F, Mattson DL, Skelton MM, Cowley AW. Localization of the vasopressin V1a and V2 receptors within the renal cortical and medullary circulation. The American Journal of Physiology. 273: R243-51. PMID 9249556 DOI: 10.1152/Ajpregu.1997.273.1.R243  0.412
Show low-probability matches.